These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9566226)
1. Sensitivity of Leishmania spp. to glibenclamide and 4-aminopyridine: a tool for the study of drug resistance development. Ponte-Sucre A; Campos Y; Vázquez J; Moll H; Mendoza-León A Mem Inst Oswaldo Cruz; 1997; 92(5):601-6. PubMed ID: 9566226 [TBL] [Abstract][Full Text] [Related]
2. Changes in the infectivity, pyruvate kinase activity, acid phosphatase activity and P-glycoprotein expression in glibenclamide-resistant Leishmania mexicana. García N; Figarella K; Mendoza-León A; Ponte-Sucre A Parasitol Res; 2000 Nov; 86(11):899-904. PubMed ID: 11097297 [TBL] [Abstract][Full Text] [Related]
3. Cell differentiation and infectivity of Leishmania mexicana are inhibited in a strain resistant to an ABC-transporter blocker. Silva N; Camacho N; Figarella K; Ponte-Sucre A Parasitology; 2004 Jun; 128(Pt 6):629-34. PubMed ID: 15206465 [TBL] [Abstract][Full Text] [Related]
4. Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis. Serrano-Martín X; Payares G; Mendoza-León A Antimicrob Agents Chemother; 2006 Dec; 50(12):4214-6. PubMed ID: 17015627 [TBL] [Abstract][Full Text] [Related]
5. Leishmania sp.: growth and survival are impaired by ion channel blockers. Ponte-Sucre A; Campos Y; Fernandez M; Moll H; Mendoza-León A Exp Parasitol; 1998 Jan; 88(1):11-9. PubMed ID: 9501844 [TBL] [Abstract][Full Text] [Related]
6. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957 [TBL] [Abstract][Full Text] [Related]
7. Substrate preferences and glucose uptake in glibenclamide-resistant Leishmania parasites. Uzcategui NL; Figarella K; Camacho N; Ponte-Sucre A Comp Biochem Physiol C Toxicol Pharmacol; 2005; 140(3-4):395-402. PubMed ID: 15886061 [TBL] [Abstract][Full Text] [Related]
8. Leishmania amazonensis: metabolic adaptations induced by resistance to an ABC transporter blocker. Machuca C; Rodríguez A; Herrera M; Silva S; Ponte-Sucre A Exp Parasitol; 2006 Sep; 114(1):1-9. PubMed ID: 16545807 [TBL] [Abstract][Full Text] [Related]
9. Experimental leishmaniasis: synergistic effect of ion channel blockers and interferon-gamma on the clearance of Leishmania major by macrophages. Ponte-Sucre A; Mendoza-León A; Moll H Parasitol Res; 2001 Jan; 87(1):27-31. PubMed ID: 11199845 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Grogl M; Thomason TN; Franke ED Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070 [TBL] [Abstract][Full Text] [Related]
11. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Légaré D; Papadopoulou B; Roy G; Mukhopadhyay R; Haimeur A; Dey S; Grondin K; Brochu C; Rosen BP; Ouellette M Exp Parasitol; 1997 Nov; 87(3):275-82. PubMed ID: 9371094 [TBL] [Abstract][Full Text] [Related]
12. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa. Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
14. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility. Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396 [TBL] [Abstract][Full Text] [Related]
15. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. Papadopoulou B; Roy G; Dey S; Rosen BP; Ouellette M J Biol Chem; 1994 Apr; 269(16):11980-6. PubMed ID: 7909316 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species. Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319 [TBL] [Abstract][Full Text] [Related]
17. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice. Jabini R; Jaafari MR; Vahdati Hasani F; Ghazizadeh F; Khamesipour A; Karimi G Drug Res (Stuttg); 2015 Mar; 65(3):119-24. PubMed ID: 24623031 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components. Grogl M; Martin RK; Oduola AM; Milhous WK; Kyle DE Am J Trop Med Hyg; 1991 Jul; 45(1):98-111. PubMed ID: 1678253 [TBL] [Abstract][Full Text] [Related]
19. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. Grondin K; Haimeur A; Mukhopadhyay R; Rosen BP; Ouellette M EMBO J; 1997 Jun; 16(11):3057-65. PubMed ID: 9214623 [TBL] [Abstract][Full Text] [Related]
20. Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae. Papadopoulou B; Roy G; Dey S; Rosen BP; Olivier M; Ouellette M Biochem Biophys Res Commun; 1996 Jul; 224(3):772-8. PubMed ID: 8713121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]